Emily’s Entourage Awards Translational Research Grant to Accelerate Prime Editing for Hard-to-Treat Cystic Fibrosis Mutations
The newly funded project will harness high-throughput gene editing and computational modeling to develop tailored therapies for people with cystic fibrosis unable to benefit from currently available mutation-targeted therapies. Lower Merion, PA—June 24, 2025—Emily’s Entourage (EE), an innovative 501(c)(3) organization accelerating research for individuals with cystic fibrosis (CF) who do not benefit from existing CFTR modulator therapies, has awarded a 2025 Translational... Per saperne di più